CBD Global Sciences Inc. (CBDN.CN) Research

CBD Global Sciences Inc. operates across the entire spectrum of cannabidiol (CBD) activities, from cultivating the plant to processing it and ultimately manufacturing finished CBD products. The company provides a range of items, including raw CBD biomass, refined CBD oil, and various consumer products containing CBD oil, all distributed under its proprietary brands: Aethics, CannaOil, and Strasburg Pharms. Established in 2018, the firm maintains its primary business operations in Lakewood, Colorado.

Market snapshot

Symbol
CBDN.CN
Price
$0.05
Day change
0.00%
Market cap
$1.6M
P/E ratio
-0.20x
52-week range
0.03-0.16
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic

Peer companies

  • Aion Therapeutic Inc. (AION.CN)
  • Craftport Cannabis Corp. (CFT.CN)
  • Choom Holdings Inc. (CHOO.CN)
  • Fiore Cannabis Ltd. (FIOR.CN)
  • Flower One Holdings Inc. (FONE.CN)
  • Isracann Biosciences Inc. (IPOT.CN)
  • Juva Life Inc. (JUVA.CN)
  • Poko Innovations Inc. (POKO.CN)

Open CBD Global Sciences Inc. (CBDN.CN) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.